Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/123192 |
Resumo: | Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance. |
id |
UFRGS-20_59558201d9bf348ea72604f582a1c9bf |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/123192 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance.Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance.HCPA/FAMED/UFRGS2023-01-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/123192Clinical & Biomedical Research; Vol. 42 No. 3 (2022): Clinical & Biomedical ResearchClinical and Biomedical Research; v. 42 n. 3 (2022): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/123192/87704Copyright (c) 2022 Luyze Homem de Jesus, Fernando Eibs Cafrune, Mariele Bevilaqua, Marina Resener de Moraishttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Eibs Cafrune, FernandoResener de Morais, MarinaBevilaqua, Mariele de Jesus, Luyze Homem2024-01-19T14:12:21Zoai:seer.ufrgs.br:article/123192Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:12:21Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
title |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
spellingShingle |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? Eibs Cafrune, Fernando |
title_short |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
title_full |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
title_fullStr |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
title_full_unstemmed |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
title_sort |
Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger? |
author |
Eibs Cafrune, Fernando |
author_facet |
Eibs Cafrune, Fernando Resener de Morais, Marina Bevilaqua, Mariele de Jesus, Luyze Homem |
author_role |
author |
author2 |
Resener de Morais, Marina Bevilaqua, Mariele de Jesus, Luyze Homem |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Eibs Cafrune, Fernando Resener de Morais, Marina Bevilaqua, Mariele de Jesus, Luyze Homem |
description |
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic pattern known as Christmas tree after receiving the first dose of the Oxford- AstraZeneca COVID-19 vaccine, similar to pityriasis rosea (PR). He had no previous symptoms of viral infection and tested negative for neutralizing antibodies (enzyme immunoassay) against COVID-19. There are few reports in the literature about the relationship between the onset of cutaneous adverse reactions and the Oxford-AstraZeneca vaccine, therefore, the disseminationof this case is of paramount importance. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-01-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliado por pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/123192 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/123192 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/123192/87704 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 42 No. 3 (2022): Clinical & Biomedical Research Clinical and Biomedical Research; v. 42 n. 3 (2022): Clinical and Biomedical Research 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767056366698496 |